Associations of circulating advanced glycation end products and their soluble receptors with cancer risk: A systematic review and meta-analysis of observational studies

IF 2.7 4区生物学 Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY Glycoconjugate Journal Pub Date : 2024-03-18 DOI:10.1007/s10719-024-10147-w

{"title":"Associations of circulating advanced glycation end products and their soluble receptors with cancer risk: A systematic review and meta-analysis of observational studies","authors":"","doi":"10.1007/s10719-024-10147-w","DOIUrl":null,"url":null,"abstract":"<h3>Abstract</h3> <p>Advanced glycation end products (AGE) in complex with their receptors (RAGE) cause a chronic inflammatory state in the body, which is the major mechanism in cancer development. This study aimed to conduct a systematic review and meta-analysis on the observational studies investigating the association between AGEs / sRAGE and cancer incidence. The PubMed, Scopus, and Web of Science databases were comprehensively searched to identify papers focused on the associations of sRAGE and AGEs with cancer incidence up to May 2023. Eight studies with a total of 7690 participants were included in the analysis to evaluate the association between circulating sRAGE and cancer incidence. The results indicated that circulating sRAGE (per 100 ng/L) had a significant inverse association with cancer incidence (RR 0.977; 95% CI 0.956, 0.999; p = 0.036; <em>I</em> <sup>2</sup> = 73.3%). The association between AGEs and cancer incidence was evaluated in 8 studies with a total of 3718 individuals. Serum concentrations of AGEs (per 100 µg/L) were not associated with the risk of cancer incidence (RR 0.988; 95% CI 0.974, 1.002; p = 0.08; <em>I2</em> = 78.8%). Our findings revealed that a higher circulating sRAGE may have a protective effect against cancer incidence.</p> <span> <h3>Graphical Abstract</h3> <p> <span> <span> <img alt=\"\" src=\"https://static-content.springer.com/image/MediaObjects/10719_2024_10147_Figa_HTML.png\"/> </span> </span></p> </span>","PeriodicalId":12762,"journal":{"name":"Glycoconjugate Journal","volume":"2 1","pages":""},"PeriodicalIF":2.7000,"publicationDate":"2024-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Glycoconjugate Journal","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1007/s10719-024-10147-w","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Advanced glycation end products (AGE) in complex with their receptors (RAGE) cause a chronic inflammatory state in the body, which is the major mechanism in cancer development. This study aimed to conduct a systematic review and meta-analysis on the observational studies investigating the association between AGEs / sRAGE and cancer incidence. The PubMed, Scopus, and Web of Science databases were comprehensively searched to identify papers focused on the associations of sRAGE and AGEs with cancer incidence up to May 2023. Eight studies with a total of 7690 participants were included in the analysis to evaluate the association between circulating sRAGE and cancer incidence. The results indicated that circulating sRAGE (per 100 ng/L) had a significant inverse association with cancer incidence (RR 0.977; 95% CI 0.956, 0.999; p = 0.036; I ² = 73.3%). The association between AGEs and cancer incidence was evaluated in 8 studies with a total of 3718 individuals. Serum concentrations of AGEs (per 100 µg/L) were not associated with the risk of cancer incidence (RR 0.988; 95% CI 0.974, 1.002; p = 0.08; I2 = 78.8%). Our findings revealed that a higher circulating sRAGE may have a protective effect against cancer incidence.

Graphical Abstract

Abstract Image

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

循环中的高级糖化终产物及其可溶性受体与癌症风险的关系：观察性研究的系统回顾和荟萃分析

摘要高级糖化终产物（AGE）与其受体（RAGE）复合物会导致体内慢性炎症状态，这是癌症发生的主要机制。本研究旨在对研究 AGEs / sRAGE 与癌症发病率之间关系的观察性研究进行系统回顾和荟萃分析。研究人员对 PubMed、Scopus 和 Web of Science 数据库进行了全面检索，以确定截至 2023 年 5 月有关 sRAGE 和 AGEs 与癌症发病率相关性的论文。分析纳入了 8 项研究，共有 7690 人参与，以评估循环 sRAGE 与癌症发病率之间的关系。结果表明，循环 sRAGE（每 100 纳克/升）与癌症发病率呈显著的反向关系（RR 0.977；95% CI 0.956，0.999；p = 0.036；I 2 = 73.3%）。共有 8 项研究对 AGEs 与癌症发病率之间的关系进行了评估，共涉及 3718 人。血清中 AGEs 的浓度（每 100 微克/升）与癌症发病风险无关（RR 0.988；95% CI 0.974，1.002；P = 0.08；I2 = 78.8%）。我们的研究结果表明，较高的循环sRAGE可能对癌症发病率有保护作用。图表摘要

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Glycoconjugate Journal 生物-生化与分子生物学

CiteScore

6.00

自引率

3.30%

发文量

审稿时长

1 months

期刊介绍： Glycoconjugate Journal publishes articles and reviews on all areas concerned with: function, composition, structure, biosynthesis, degradation, interactions, recognition and chemo-enzymatic synthesis of glycoconjugates (glycoproteins, glycolipids, oligosaccharides, polysaccharides and proteoglycans), biochemistry, molecular biology, biotechnology, immunology and cell biology of glycoconjugates, aspects related to disease processes (immunological, inflammatory, arthritic infections, metabolic disorders, malignancy, neurological disorders), structural and functional glycomics, glycoimmunology, glycovaccines, organic synthesis of glycoconjugates and the development of methodologies if biologically relevant, glycosylation changes in disease if focused on either the discovery of a novel disease marker or the improved understanding of some basic pathological mechanism, articles on the effects of toxicological agents (alcohol, tobacco, narcotics, environmental agents) on glycosylation, and the use of glycotherapeutics. Glycoconjugate Journal is the official journal of the International Glycoconjugate Organization, which is responsible for organizing the biennial International Symposia on Glycoconjugates.